DOPHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

24/11/2020

VAT status

Active

Bankruptcy proceedings

No proceedings

DOPHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

High

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Incorporation date

19/11/2020

Share capital

5,000.00 PLN

Primary activity

Wholesale of pharmaceutical goods (46.46.Z - PKD 2007)

Representatives

Representatives rights

W PRZYPADKU ZARZĄDU JEDNOOOSOBOWEGO DO SKŁADANIA OŚWIADCZEŃ WOLI W IMIENIU SPÓŁKI PREZES ZARZĄDU UPRAWNIONY JEST SAMOZIELNIE, NATOMIAST W PRZYPADKU POWOŁANIA ZARZĄDU WIELOOSOBOWEGO DO SKŁADANIA OŚWIADCZEŃ WOLI W IMIENIU SPÓŁKI KAŻDY Z CZŁONKÓW ZARZĄDU (ZARÓWNO PREZES ZARZĄDU, JAK I POSZCZEGÓLNI CZŁONKOWIE ZARZĄDU) SĄ UPRAWNIENI SAMODZIELNIE.

Representatives

Vice-president of the management boardI******* F******

Chairman of the management boardW****** D********

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
I***** F****	Vice-president of the management board
W**** D******	Chairman of the management board

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

1,613,018

Net Profit (zł)

1,613,018

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
43,581,175
1,518,216
1,196,924
0.07
1.20
2.75
2,102,153
14,778,288
446,116
634,597

2023
66,463,298
2,474,861
1,944,218
0.06
1.30
2.93
4,046,371
14,072,640
528,472
1,255,265

2024
80,611,417
2,046,954
1,613,018
0.03
1.16
2.00
3,996,665
17,591,504
244,202
-

2024
80,611,417
2,046,954
1,613,018
0.03
1.16
2.00
3,996,665
17,591,504
244,202
-

Turnover (zł)

2024

Turnover (zł)

80,611,417 zł21 % *

Profit before tax (zł)

2,046,954 zł-17 % *

Net Profit (zł)

1,613,018 zł-17 % *

Working capital requirement (%)

0.03 -50.00 % *

Liquidity ratio

1.16 -10.77 % *

Net profitability (%)

2.00 %-31.74 % *

Equity (zł)

3,996,665 zł-1 % *

Current liabilities (zł)

17,591,504 zł25 % *

Non current liabilities (zł)

244,202 zł-54 % *

Non-current Assets (zł)

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

DOPHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
15/04/2025	OD 01.01.2024 DO 31.12.2024
08/07/2024	OD 01.01.2023 DO 31.12.2023
07/06/2023	OD 01.01.2022 DO 31.12.2022
21/06/2022	OD 08.09.2020 DO 31.12.2021